Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-008451

Chief Business Officer sold 4,267 shares at $13.89 ($59,272)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Loerop James Chief Business Officer 2023-02-08 Sale −4,267 $13.89 $59,272 6,983 D
Open-market sales · 4,267 sh · avg $13.89 · $59,272
Loading xslF345X03/doc4.xml…